Skip to main content
Veterinary Medicines

Giraxa, 50mg/g, Powder for oral solution

Authorised
  • Colistin

Product identification

Medicine name:
Giraxa, 50mg/g, Powder for oral solution
GIRAXA 50 mg/g, milteliai geriamajam tirpalui ruošti veršeliams, paršeliams ir viščiukams
Active substance:
  • Colistin
Target species:
  • Chicken (broiler)
  • Cattle (calf)
  • Pig (piglet)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Colistin
    1200000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (broiler)
      • Meat and offal
        1
        day
      • Egg
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        1
        day
    • Pig (piglet)
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA10
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Plastic Sachet 1 x 100.0 gram(s)
  • Plastic Sachet 1 x 1000.0 gram(s)
  • Plastic Vial 1 x 100.0 gram(s)
  • Plastic Vial 1 x 1000.0 gram(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/08/1785/001-004
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0103/001
Concerned member states:
  • Latvia
  • Lithuania
  • Poland
  • Slovenia

Documents

RV1785.pdf

Lithuanian (PDF)
Published on: 24/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."